As of Sep 20
| +0.22 / +6.65%|
The 3 analysts offering 12-month price forecasts for Anavex Life Sciences Corp have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 10.00. The median estimate represents a +183.29% increase from the last price of 3.53.
The current consensus among 3 polled investment analysts is to Buy stock in Anavex Life Sciences Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.